TY - JOUR T1 - <em>TERT</em> promoter mutations in periocular carcinomas: implications of ultraviolet light in pathogenesis JF - British Journal of Ophthalmology JO - Br J Ophthalmol SP - 274 LP - 277 DO - 10.1136/bjophthalmol-2015-307503 VL - 100 IS - 2 AU - Shih-Yao Lin AU - Shu-Lang Liao AU - Jin-Bon Hong AU - Chia-Yu Chu AU - Yi-Shuan Sheen AU - Jie-Yang Jhuang AU - Jia-Huei Tsai AU - Jau-Yu Liau Y1 - 2016/02/01 UR - http://bjo.bmj.com/content/100/2/274.abstract N2 - Background/aims Ultraviolet light-signature mutations in the telomerase reverse transcriptase (TERT) gene promoter have been identified in cutaneous melanomas, basal cell carcinomas (BCCs), and squamous cell carcinomas (SCCs). Whether these mutations also occur in periocular tumours, including periocular sebaceous carcinomas (PSCs) and in situ tumours, has not been studied.Methods DNA extraction, PCR and Sanger sequencing were used to determine the frequency of TERT promoter mutations in periocular tumours. The presence of mutations was correlated with histological evidence of solar elastosis.Results Sixty-three tumours were analysed. TERT promoter mutations were identified in 18 of 22 BCCs (82%), 6 of 10 SCCs (60%), 1 of 2 in situ SCCs (50%), 4 of 9 grade III conjunctival intraepithelial neoplasia (CIN III) (44%) and 0 of 20 PSCs (0%). For BCCs, TERT promoter mutations were not associated with the histological risk categories of the tumours. For CIN III cases, all of the three lesions with solar elastosis had TERT promoter mutations, whereas the mutation was found in only one of the six CIN III cases without solar elastosis.Conclusions We demonstrate that ultraviolet light-signature TERT promoter mutations are very common in periocular BCCs, SCCs and CIN III lesions, indicating important roles of ultraviolet light in the pathogenesis of these tumours. In addition, the mutations are present in in situ stage. By contrast, no TERT promoter mutation is found in PSCs. ER -